Literature DB >> 28382470

Comorbidities in Heart Failure.

Haye H van der Wal1, Vincent M van Deursen1, Peter van der Meer1, Adriaan A Voors2,3.   

Abstract

Comorbidities frequently accompany chronic heart failure (HF), contributing to increased morbidity and mortality, and an impaired quality of life. We describe the prevalence of several high-impact comorbidities in chronic HF patients and their impact on morbidity and mortality. Furthermore, we try to explain the underlying pathophysiological processes and the complex interaction between chronic HF and specific comorbidities. Although common risk factors are likely to contribute, it is reasonable to believe that factors associated with HF might cause other comorbidities and vice versa. Potential factors are inflammation, neurohormonal activation, and hemodynamic changes.

Entities:  

Keywords:  Anemia; Cognitive dysfunction; Comorbidities; Diabetes mellitus; Heart failure; Hematinic deficiencies; Hyperkalemia; Iron deficiency; Renal failure; Sleep apnea; Sleep-disordered breathing

Mesh:

Year:  2017        PMID: 28382470     DOI: 10.1007/164_2017_27

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  11 in total

Review 1.  The influence of heart failure on the pharmacokinetics of cardiovascular and non-cardiovascular drugs: a critical appraisal of the evidence.

Authors:  Arduino A Mangoni; Elzbieta A Jarmuzewska
Journal:  Br J Clin Pharmacol       Date:  2018-10-14       Impact factor: 4.335

2.  Relationship of anemia and clinical outcome in heart failure patients with preserved versus reduced ejection fraction in a rural area of Thailand.

Authors:  Kittayaporn Chairat; Wipharak Rattanavipanon; Krittika Tanyasaensook; Busba Chindavijak; Suvatna Chulavatnatol; Surakit Nathisuwan
Journal:  Int J Cardiol Heart Vasc       Date:  2020-07-30

3.  Time to Death and Its Determinant Factors Among Patients With Chronic Heart Failure in Northwest Ethiopia: A Retrospective Study at Selected Referral Hospitals.

Authors:  Yikeber Abebaw Moyehodie; Mitiku Wale Muluneh; Alebachew Taye Belay; Setegn Muche Fenta
Journal:  Front Cardiovasc Med       Date:  2022-05-06

4.  Determinants of maximal oxygen uptake in patients with heart failure.

Authors:  Javier Roibal Pravio; Eduardo Barge Caballero; Cayetana Barbeito Caamaño; Maria Jesus Paniagua Martin; Gonzalo Barge Caballero; David Couto Mallon; Patricia Pardo Martinez; Zulaika Grille Cancela; Paula Blanco Canosa; Jose Manuel García Pinilla; Jose Manuel Vázquez Rodríguez; Maria Generosa Crespo Leiro
Journal:  ESC Heart Fail       Date:  2021-03-27

5.  Incremental prognostic value of cardiac metaiodobenzylguanidine imaging over the co-morbid burden in acute decompensated heart failure.

Authors:  Kiyomi Kayama; Takahisa Yamada; Shunsuke Tamaki; Tetsuya Watanabe; Takashi Morita; Yoshio Furukawa; Masato Kawasaki; Atsushi Kikuchi; Tsutomu Kawai; Masahiro Seo; Jun Nakamura; Masatsugu Kawahira; Masatake Fukunami
Journal:  ESC Heart Fail       Date:  2021-01-12

6.  Cardioprotective Effect of Paeonol on Chronic Heart Failure Induced by Doxorubicin via Regulating the miR-21-5p/S-Phase Kinase-Associated Protein 2 Axis.

Authors:  Cong Chen; Shuhong Liu; Gaozhen Cao; Yang Hu; Run Wang; Min Wu; Mingya Liu; Kai Hang Yiu
Journal:  Front Cardiovasc Med       Date:  2022-07-05

7.  Anticoagulation for atrial fibrillation in heart failure patients: balancing between Scylla and Charybdis.

Authors:  Grigorios Tsigkas; Anastasiοs Apostolos; Stefanos Despotopoulos; Georgios Vasilagkos; Angeliki Papageorgiou; Eleftherios Kallergis; Georgios Leventopoulos; Virginia Mplani; Ioanna Koniari; Dimitrios Velissaris; John Parissis
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

8.  Right Ventricular Free Wall Strain and Congestive Hepatopathy in Patients with Acute Worsening of Chronic Heart Failure: A CATSTAT-HF Echo Substudy.

Authors:  Josip A Borovac; Duska Glavas; Zora Susilovic Grabovac; Daniela Supe Domic; Lada Stanisic; Domenico D'Amario; Darko Duplancic; Josko Bozic
Journal:  J Clin Med       Date:  2020-05-02       Impact factor: 4.241

9.  Use of Idarucizumab to Revert the Anticoagulant Effect of Dabigatran in Heart Transplant Surgery: An Institutional Experience.

Authors:  Álvaro Herrera-Escandón; Orlando Castaño-Cifuentes; Carlos A Plata-Mosquera
Journal:  Case Rep Cardiol       Date:  2020-03-06

10.  Effects of enriched-potassium diet on cardiorespiratory outcomes in experimental non-ischemic chronic heart failure.

Authors:  Karla G Schwarz; Katherin V Pereyra; Camilo Toledo; David C Andrade; Hugo S Díaz; Esteban Díaz-Jara; Domiziana Ortolani; Angélica Rios-Gallardo; Paulina Arias; Alexandra Las Heras; Ignacio Vera; Fernando C Ortiz; Nibaldo C Inestrosa; Carlos P Vio; Rodrigo Del Rio
Journal:  Biol Res       Date:  2021-12-24       Impact factor: 5.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.